Preview Mode Links will not work in preview mode

The Retina Channel Podcast

The Retina Channel is an ophthalmology journal club discussing new scientific articles focused on retina. The target audience are eye care professionals who are interested in the most recent advances in retina.

“Our mission is to facilitate transmission of knowledge from researchers to their target audience.”

  1. All Episodes
  2. E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel

E28-Brolucizumab for wet AMD (HAWK and HARRIER)- Dr. Pravin Dugel

Sep 2, 2019

Dr. Dugel discusses 1 and 2 year results of HAWK and HARRIER on Brolucizumab for neovascular AMD. 

Full reference: 

Dugel, P. U., Koh, A., Ogura, Y., Jaffe, G. J., Schmidt-Erfurth, U., Brown, D. M., . . . Investigators, H. S. (2019). HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. doi:10.1016/j.ophtha.2019.04.017